Share on StockTwits

Otonomy (NASDAQ:OTIC) Insider A/S Novo bought 171,875 shares of Otonomy stock in a transaction dated Monday, August 18th. The stock was purchased at an average cost of $16.00 per share, for a total transaction of $2,750,000.00. Following the completion of the transaction, the insider now directly owns 2,159,335 shares of the company’s stock, valued at approximately $34,549,360. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Otonomy (NASDAQ:OTIC) traded down 1.50% during mid-day trading on Thursday, hitting $15.75. The stock had a trading volume of 2,448 shares. Otonomy has a 1-year low of $15.19 and a 1-year high of $18.49. The stock’s 50-day moving average is $16.31 and its 200-day moving average is $16.31. The company’s market cap is $2.0 million.

Otonomy, Inc is a clinical-stage biopharmaceutical company. The Company focused on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear.

Receive News & Ratings for Otonomy Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otonomy Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.